Complex PCI in Octogenarian

The octogenarian population has already reached 137 million and continues to grow. It is estimated to triple by 2050. 

La estrategia invasiva en pacientes frágiles es segura

This increase represents a big challenge, seeing as these patients are often more fragile, present more complex coronary artery disease and multiple comorbidities. This generally requires two or more procedures and more experience both from operators and the whole health team. 

2,657 octogenarian patients were randomized, 1,387 received complex percutaneous coronary intervention (C PCI).

Primary end point was a composite of all-cause mortality, myocardial infarction (MI) or target vessel revascularization (TVR) (MACE) at 12 months.

Mean patient age was 84, with 36% diabetic and no significant differences in kidney function. Those receiving complex PCI were more often women, smoker, hypertensive, with dyslipidemia, prior MI, prior PCI, prior CABS, atrial fibrillation and lower ejection fraction. 

Read also: High Gradients After Valve-in-Valve.

The most frequent clinical presentation was stable chronic angina, followed by unstable angina, non-ST elevation acute MI (NTEMI), ST elevation MI (STEMI), and, less frequently, silent ischemia. 

Most procedures were femoral (84%). Patients with C PCI commonly presented left main lesions, multivessel disease, lesions to the anterior descending, calcified lesions, bifurcations, longer lesions, more stents, longer stents and the need for ventricular assistance, as well as higher SYNTAX score (20.8 vs. 10.7, p<0.001).

Read also: Glycemic Control and Coronary Stent Failure.

Primary end point resulted higher in patients undergoing C PCI (16.6% vs. 11.1%, p<0.001), as well as MI incidence (4.1% vs. 1.5%, p=0.002) and TVR (8.9% vs. 4.4%, p<0.001), with no differences in all-cause mortality. Also these patients presented a higher incidence of TLR and major bleeding with no differences in post discharge stroke or major bleeding incidence. 

Conclusion

Octogenarian undergoing complex PCI are associated to higher risk of major adverse cardiovascular events (MACE) at one year, because of higher MI and TVF rate, as well as higher incidenc of major bleeding, with no difference in all-cause mortality vs. pateints undergoing non-complex PCI. We should implement strategies to reduce complications in octogenarian patients undergoing complex PCI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians. 

Reference: Alessandro Spirito, et al. Catheter Cardiovasc Interv. 2024;103:1079–1087.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...